These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24748322)

  • 21. Contributions of the N- and C-terminal helical segments to the lipid-free structure and lipid interaction of apolipoprotein A-I.
    Tanaka M; Dhanasekaran P; Nguyen D; Ohta S; Lund-Katz S; Phillips MC; Saito H
    Biochemistry; 2006 Aug; 45(34):10351-8. PubMed ID: 16922511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles.
    Nagao K; Hata M; Tanaka K; Takechi Y; Nguyen D; Dhanasekaran P; Lund-Katz S; Phillips MC; Saito H
    Biochim Biophys Acta; 2014 Jan; 1841(1):80-7. PubMed ID: 24120703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
    Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
    J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of apolipoprotein AI on nascent high-density lipoprotein particle formation].
    Wu JF; Tang YY; Zeng GF; Tang CK
    Sheng Li Ke Xue Jin Zhan; 2014 Apr; 45(2):81-6. PubMed ID: 25069300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel potent apoA-I peptide mimetics that stimulate cholesterol efflux and pre-beta particle formation in vitro.
    Ingenito R; Burton C; Langella A; Chen X; Zytko K; Pessi A; Wang J; Bianchi E
    Bioorg Med Chem Lett; 2010 Jan; 20(1):236-9. PubMed ID: 19932961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
    Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
    J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lecithin cholesterol acyltransferase (LCAT) activity in the presence of Apo-AI-derived peptides exposed to disorder-order conformational transitions.
    Aguilar-Espinosa SL; Mendoza-Espinosa P; Delgado-Coello B; Mas-Oliva J
    Biochem Biophys Res Commun; 2013 Nov; 441(2):469-75. PubMed ID: 24383078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylethanolamine accelerates aggregation of the amyloidogenic N-terminal fragment of apoA-I.
    Kurimitsu N; Mizuguchi C; Fujita K; Taguchi S; Ohgita T; Nishitsuji K; Shimanouchi T; Saito H
    FEBS Lett; 2020 May; 594(9):1443-1452. PubMed ID: 31968125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the C-terminal domain of lipid-free apoA-I demonstrates the vital role of the H10B sequence repeat in HDL formation.
    Mei X; Liu M; Herscovitz H; Atkinson D
    J Lipid Res; 2016 Aug; 57(8):1507-17. PubMed ID: 27317763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrils.
    Adachi E; Kosaka A; Tsuji K; Mizuguchi C; Kawashima H; Shigenaga A; Nagao K; Akaji K; Otaka A; Saito H
    FEBS Lett; 2014 Jan; 588(3):389-94. PubMed ID: 24316228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
    Wong YQ; Binger KJ; Howlett GJ; Griffin MD
    FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the lipid-free structure and stability of apolipoprotein A-I by mutation.
    Gorshkova IN; Liadaki K; Gursky O; Atkinson D; Zannis VI
    Biochemistry; 2000 Dec; 39(51):15910-9. PubMed ID: 11123918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation.
    Gorshkova IN; Liu T; Kan HY; Chroni A; Zannis VI; Atkinson D
    Biochemistry; 2006 Jan; 45(4):1242-54. PubMed ID: 16430220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant.
    Dalla-Riva J; Lagerstedt JO; Petrlova J
    PLoS One; 2015; 10(11):e0143915. PubMed ID: 26605794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Insights into Human Hereditary Apolipoprotein A-I Amyloidosis Caused by the Glu34Lys Mutation.
    Morgado I; Panahi A; Burwash AG; Das M; Straub JE; Gursky O
    Biochemistry; 2018 Oct; 57(39):5738-5747. PubMed ID: 30184436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional independence of a peptide with the sequence of human apolipoprotein A-I central region.
    Toledo JD; Prieto ED; Gonzalez MC; Soulages JL; Garda HA
    Arch Biochem Biophys; 2004 Aug; 428(2):188-97. PubMed ID: 15246876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin promotes fibril formation by the N-terminal fragment of amyloidogenic apolipoprotein A-I.
    Mikawa S; Mizuguchi C; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Sakashita N; Otaka A; Akaji K; Saito H
    FEBS Lett; 2016 Oct; 590(20):3492-3500. PubMed ID: 27654470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux.
    Gillotte KL; Davidson WS; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 1996 Sep; 271(39):23792-8. PubMed ID: 8798607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I.
    Koyama M; Tanaka M; Dhanasekaran P; Lund-Katz S; Phillips MC; Saito H
    Biochemistry; 2009 Mar; 48(11):2529-37. PubMed ID: 19239199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.